Cargando…
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
OBJECTIVES: Multiple mechanisms have been proposed to explain disease severity in coronavirus disease 2019. Therapeutic approaches need to be underpinned by sound biological rationale. We evaluated whether serum levels of a range of proposed coronavirus disease 2019 therapeutic targets discriminated...
Autores principales: | Arulkumaran, Nishkantha, Snow, Timothy Arthur Chandos, Kulkarni, Adarsh, Brealey, David, Rickman, Hannah, Rees-Spear, Chloe, Spyer, Moira J., Heaney, Judith, Garr, Edmund, Williams, Bryan, Cherepanov, Peter, Kassiotis, George, Lunn, Michael, Houlihan, Catherine, McCoy, Laura E., Nastouli, Eleni, Singer, Mervyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352605/ https://www.ncbi.nlm.nih.gov/pubmed/34386774 http://dx.doi.org/10.1097/CCE.0000000000000488 |
Ejemplares similares
-
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021) -
Influence of IL-6 levels on patient survival in COVID-19
por: Arulkumaran, Nishkantha, et al.
Publicado: (2021) -
Steroids in ARDS: more light is being shed
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021) -
Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)